DEUTSCHE BANK AG\ - CELLECT BIOTECHNOLOGY LTD ownership

CELLECT BIOTECHNOLOGY LTD's ticker is APOP and the CUSIP is 15116C102. A total of 6 filers reported holding CELLECT BIOTECHNOLOGY LTD in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of CELLECT BIOTECHNOLOGY LTD
ValueSharesWeighting
Q3 2019$8,000
-68.0%
17,933
-64.1%
0.00%
Q2 2019$25,00050,000
+24900.0%
0.00%
Q1 2019$0
-100.0%
200
-60.0%
0.00%
Q2 2017$4,0005000.00%
Other shareholders
CELLECT BIOTECHNOLOGY LTD shareholders Q2 2017
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 487,960$3,114,0000.19%
American Portfolios Advisors 1,000$6,3800.00%
CIBC Private Wealth Group, LLC 50$00.00%
CITIGROUP INC 9,740$62,0000.00%
MORGAN STANLEY 14,869$95,0000.00%
Migdal Insurance & Financial Holdings Ltd. 1,555$10,0000.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 67,962$434,0000.00%
BANK OF AMERICA CORP /DE/ 5$00.00%
View complete list of CELLECT BIOTECHNOLOGY LTD shareholders